FULC
USDFulcrum Therapeutics Inc. Common Stock
$5.620+1.210 (27.438%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.410
High
$6.150
Low
$4.380
Volume
0.34M
Company Fundamentals
Market Cap
303.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.46M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.315Current $5.620High $10.13
Related News
GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients
View more
Related Stocks
AJX
Great Ajax Corp.
NASDAQ
Real Estate Inv...
CL
Colgate-Palmolive Company
NASDAQ
Package Goods/C...
CAF
Morgan Stanley China A Share Fund Inc.
NASDAQ
Investment Mana...
EOI
Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
NASDAQ
Finance/Investo...
LFMD
LifeMD Inc.
NASDAQ
Medical/Nursing...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.